| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On October 4, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
|
|
| 1980N-0280
|
| Vaginal Contraceptive Drug Products for OTC Use
|
|
|
|
|
| 1995N-0309
|
| CGMPs for the Production of Infant Formula
|
|
|
|
|
| 2006M-0396
|
| P050038 - Arista AH Absorbable Hemostat
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| 2006P-0405
|
| Require that the full prescribing information of all antiepileptic drugs contain the following language under Warnings or Warnings and Precautions
|
|
| |
|
| 1978N-0036L
|
| OTC Laxative
|
|
|
| LET 205
|
| FDA/CDER to The Purdue Frederick Company
|
| Vol #:
|
| 138
|
|
|
|
|
| 1980N-0280
|
| Vaginal Contraceptive Drug Products for OTC Use
|
|
|
|
|
| LET 9
|
| FDA/CDER to Regulatory & Scientific Affairs
|
| Vol #:
|
| 12
|
|
|
|
|
| 1995N-0309
|
| CGMPs for the Production of Infant Formula
|
|
|
|
|
| EMC 11
|
| International Formula Council
|
| Vol #:
|
| 14
|
|
|
|
|
| EMC 12
|
| P. B. M. Nutritionals
|
| Vol #:
|
| 15
|
|
|
|
|
| 2006M-0396
|
| P050038 - Arista AH Absorbable Hemostat
|
|
|
|
|
| AAV 1
|
| Medafor, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
|
|
| C 3
|
| D. Reuben
|
| Vol #:
|
| 1
|
|
|
|
|
| C 4
|
| Form Letter Count
|
| Vol #:
|
| 5
|
|
| |
|
| 2006P-0405
|
| Require that the full prescribing information of all antiepileptic drugs contain the following language under Warnings or Warnings and Precautions
|
|
|
|
|
| ACK 1
|
| FDA/DDM to UCB, Inc
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| UCB, Inc
|
| Vol #:
|
| 1
|
|
